Trial Information

Summary: A Phase III, Multicenter, Randomized,Double-Blind,Placebo-Controlled Study to Assess Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region

This study is for patients who have received radiation therapy for the treatment of cancer of head and neck. It is designed to evaluate the use of a drug, cevimeline, in patients with dry mouth (xerostomia).
Compensation Provided

Patient Inclusion/Exclusion Criteria:

Dry mouth
Age >18 years
Not pregnant
History of radiation therapy to head and neck

History of Cevimeline use
History of significant heart, lung, kidney and liver problems
History of glaucoma or iritis
History of Sjogren's syndrome

Contact:

Lyudmila Milman, Physician Assistant
Mount Sinai Medical Center
One Gustave L. Levy Place

New York, NY 10029
Telephone: 212 241-5931/0158
Fax: 212 831-3700
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:29 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA